Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(20%)

Phase Distribution

Ph not_applicable
3
60%
Ph phase_4
1
20%
Ph early_phase_1
1
20%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(2)
Terminated(1)
Other(2)

Detailed Status

unknown2
Completed2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (20.0%)
Phase 41 (20.0%)
N/A3 (60.0%)

Trials by Status

terminated120%
unknown240%
completed240%

Recent Activity

Clinical Trials (5)

Drug Details

Intervention Type
PROCEDURE
Total Trials
5